SCHEMBL12418958

SCHEMBL12418958

COC(=O)CC1CC2C3CCc4cc(O)ccc4C3CC[C@]2(C)C1=O

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 11/20 0.82
AKR1C3 P42330 1/20 0.58
ESR1 P03372 6/20 0.58
ESR2 Q92731 4/20 0.58
CYP3A4 P08684 2/20 0.58
MAPT P10636 2/20 0.58
LMNA P02545 2/20 0.58
SHBG P04278 2/20 0.58
PGR P06401 2/20 0.58
SERPINA6 P08185 2/20 0.58
AR P10275 2/20 0.58
SLC6A4 P31645 2/20 0.58
SNCA P37840 2/20 0.58
SLC6A3 Q01959 2/20 0.58
HIF1A Q16665 2/20 0.58
AKR1B10 O60218 1/20 0.58
CYP1A2 P05177 1/20 0.58
STS P08842 1/20 0.58
CYP19A1 P11511 1/20 0.58
AKR1B1 P15121 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12379501 0.90 HSD17B1 (1.00) HSD17B1AKR1C3ESR1ESR2CYP3A4
SCHEMBL12593969 0.89 HSD17B1 (0.80) HSD17B1AKR1C3ESR1ESR2CYP3A4
SCHEMBL12379508 0.89 HSD17B1 (0.80) HSD17B1AKR1C3ESR1ESR2CYP3A4
SCHEMBL12379562 0.88 HSD17B1 (1.00) HSD17B1AKR1C3ESR1ESR2CYP3A4
SCHEMBL12379557 0.87 HSD17B1 (0.82) HSD17B1AKR1C3ESR1ESR2CYP3A4
SCHEMBL12379530 0.86 HSD17B1 (0.76) HSD17B1AKR1C3ESR1ESR2CYP3A4
SCHEMBL12418333 0.86 HSD17B1 (0.63) HSD17B1CYP3A4MAPTLMNASTS
SCHEMBL12379559 0.86 HSD17B1 (0.81) HSD17B1AKR1C3ESR1ESR2CYP3A4
SCHEMBL15307738 0.86 HSD17B1 (0.79) HSD17B1ESR1ESR2CYP3A4MAPT
SCHEMBL12379386 0.85 HSD17B1 (0.68) HSD17B1AKR1C3ESR1ESR2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003783-B2 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer STERIX LIMITED (GB) 2011-08-23 US disclosed